Screener
Zevra Therapeutics, Inc. ZVRA Impairment Charges
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s impairment charges?
- Zevra Therapeutics, Inc. (ZVRA) reported impairment charges of $0 in Q2 2026.
- What does impairment charges mean?
- Write-downs of long-lived assets (excluding goodwill) when their carrying value exceeds fair value, including property, equipment, right-of-use assets, and other tangible assets.
Ask your AI about Zevra Therapeutics, Inc.'s impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude